Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Are there any side effects associated with olaparib in recent us clinical trials?

See the DrugPatentWatch profile for olaparib

What side effects appeared in recent US clinical trials for olaparib?

Recent US clinical trials for olaparib reported anemia, fatigue, nausea, vomiting, and diarrhea as the most common side effects. Anemia occurred in 41% of patients overall and in 21% grade 3 or higher cases. Fatigue appeared in 30% of patients. Nausea reached 58%, vomiting 30%, and diarrhea 34%. Grade 3 or higher versions of these gastrointestinal issues remained low at roughly 2–3%.



Other Questions About Olaparib :

What's the expected timeframe for olaparib's widespread adoption? Are there any ongoing olaparib trials for specific cancer types? Are there any expired olaparib patents in the us? What are olaparib's mechanisms in ovarian cancer therapy? What's the status of new olaparib patents in the us? What's the expected timeframe for olaparib's widespread adoption? Are there new us patents pending for olaparib?